Skip to main content
. 2022 Jul 13;135(13):1531–1538. doi: 10.1097/CM9.0000000000002104

Table 2.

Summary of adverse events in the safety population.

Adverse events Grade SOC plus arbidol (n = 200) SOC (n = 33)
Hepatic function damage 1 1 (0.5) 0 (0)
Low leucocyte count 1 2 (1.0) 4 (12.1)
2 2 (1.0) 1 (3.0)
Alanine aminotransferase increased 1 4 (2.0) 1 (3.0)
2 1 (0.5) 0 (0)
Decreased platelet count 1 1 (0.5) 0 (0)
Decreased neutrophil count 1 3 (1.5) 1 (3.0)
2 2 (1.0) 0 (0)
Anemia 1 5 (2.5) 1 (3.0)
2 1 (0.5) 0 (0)

Data are presented as n (%). SOC: Standard of care.